The 2022 Novo Nordisk Prize will recognize an active scientist for her/his excellent research, inspirational leadership and mentoring, leading to a major discovery or breakthrough in biomedical science. Since 2020, the Prize is awarded to excellent scientists based in academic institutions or companies conducting research in Europe. The prize is intended to award and further support biomedical research in Europe. The Novo Nordisk Prize is administered and sponsored by the Novo Nordisk Foundation, based in Denmark.
*The Prize is of DKK 5 million (appr. EUR 672,000) and consist of a DKK 4,5 million (appr. EUR 605,000) research grant and a personal award of DKK 0,5 million (appr. EUR 67,000). The Foundation will grant an additional DKK 0,5 million for hosting an international symposium within the awardee’s field(s) of research.
Nominations must be submitted via the online nomination form, latest 1 June 2021.
Criteria and eligibility requirements to be found either on the Novo Nordisk Prize webpage or in attached pdf.
For any questions, please contact the Foundation’s Scientific Secretariat at firstname.lastname@example.org.
For more information on the Novo Nordisk Foundation, please visit: https://novonordiskfonden.dk/en/
The Prize Committee will select awardees based on their scientific achievements and impact on the scientific community. The Novo Nordisk Prize Awardee will be announced in Spring 2022.
Nomination closes on 1 June 2021.